Thursday 12 May 2016

Over 3500 delegates attended the 2nd European Stroke Organisation Conference (ESOC 2016)  in Barcelona this week. 

Click on the links below to view video interviews with lead researchers on the following trials:

ENCHANTED – effects of lower dosage of clot busting drug for treating acute ischaemic stroke.

SOCRATES -  use of ticagrelor vs aspirin in acute stroke and TIA.

ATTACH II  - anti-hypertensive treatment of acute cerebral bleeding.

ARUBA – do we treat unruptured AV malformations?

PATCH – platelet transfusion to patients with intracerebral bleeding type stroke.

PreDIVA – treating vascular risk factors to prevent dementia.

VIST –how to prevent stroke in the arteries of the back of the brain.

CLEAR III –low dose clot busting drug for patients with intraventicular bleeding type stroke.

IST – third international stroke trial - long term effects of clot-busting drug alteplase for treating acute ischaemic stroke.

SIESTA – how patients could be sedated when receiving mechanical clot retrieval for ischaemic stroke.

News type
Tags

Share